β‐Adrenergic modulation of skeletal muscle contraction: key role of excitation–contraction coupling
Year: 2015
Type: review
Abstract: Our aim is to describe the acute effects of catecholamines/β-adrenergic agonists on contraction of non-fatigued skeletal muscle in animals and humans, and explain the mechanisms involved. Adrenaline/β-agonists (0.1-30 μm) generally augment peak force across animal species (positive inotropic effect) and abbreviate relaxation of slow-twitch muscles (positive lusitropic effect). A peak force reduction also occurs in slow-twitch muscles in some conditions. β2 -Adrenoceptor stimulation activates distinct cyclic AMP-dependent protein kinases to phosphorylate multiple target proteins. β-Agonists modulate sarcolemmal processes (increased resting membrane potential and action potential amplitude) via enhanced Na(+) -K(+) pump and Na(+) -K(+) -2Cl(-) cotransporter function, but this does not increase force. Myofibrillar Ca(2+) sensitivity and maximum Ca(2+) -activated force are unchanged. All force potentiation involves amplified myoplasmic Ca(2+) transients consequent to increased Ca(2+) release from sarcoplasmic reticulum (SR). This unequivocally requires phosphorylation of SR Ca(2+) release channels/ryanodine receptors (RyR1) which sensitize the Ca(2+) -induced Ca(2+) release mechanism. Enhanced trans-sarcolemmal Ca(2+) influx through phosphorylated voltage-activated Ca(2+) channels contributes to force potentiation in diaphragm and amphibian muscle, but not mammalian limb muscle. Phosphorylation of phospholamban increases SR Ca(2+) pump activity in slow-twitch fibres but does not augment force; this process accelerates relaxation and may depress force. Greater Ca(2+) loading of SR may assist force potentiation in fast-twitch muscle. Some human studies show no significant force potentiation which appears to be related to the β-agonist concentration used. Indeed high-dose β-agonists (∼0.1 μm) enhance SR Ca(2+) -release rates, maximum voluntary contraction strength and peak Wingate power in trained humans. The combined findings can explain how adrenaline/β-agonists influence muscle performance during exercise/stress in humans.
Source: The Journal of Physiology
DOI: 10.1113/jp270909
Authors: Simeon P. Cairns, Fabio Borrani
Institutions: Auckland University of Technology, University of Lausanne
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: beta-adrenergic agonists, epinephrine, skeletal muscle contraction, excitation-contraction coupling, positive inotropic effect, ryanodine receptor phosphorylation, sarcoplasmic reticulum Ca2+ release, Na+-K+-2Cl- cotransporter, Na+/K+-ATPase, phospholamban, protein kinase A, slow-twitch muscle, fast-twitch muscle, diaphragm
Open Access status: green
Funder: Université de Montpellier
OpenAlex ID: W2133621497
